Compounds > erlotinib
Page last updated: 2024-09-05

erlotinib and cudc-907

erlotinib has been researched along with cudc-907 in 2 studies

Compound Research Comparison

Studies
(erlotinib)		Trials
(erlotinib)		Recent Studies (post-2010)
(erlotinib)		Studies
(cudc-907)		Trials
(cudc-907)		Recent Studies (post-2010) (cudc-907)
221018057355

Protein Interaction Comparison

ProteinTaxonomyerlotinib (IC50)cudc-907 (IC50)
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoformHomo sapiens (human)0.0869
Histone deacetylase 3Homo sapiens (human)0.0029
Phosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)0.0712
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoformHomo sapiens (human)0.0246
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoformHomo sapiens (human)0.0439
Serine/threonine-protein kinase mTORHomo sapiens (human)0.308
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)0.209
Histone deacetylase 4Homo sapiens (human)0.3233
DNA-dependent protein kinase catalytic subunitHomo sapiens (human)3.673
Histone deacetylase 1Homo sapiens (human)0.0022
Histone deacetylase 7Homo sapiens (human)0.2828
Histone deacetylase 2Homo sapiens (human)0.0052
Polyamine deacetylase HDAC10Homo sapiens (human)0.0036
Histone deacetylase 11 Homo sapiens (human)0.2039
Histone deacetylase 8Homo sapiens (human)0.145
Histone deacetylase 6Homo sapiens (human)0.1039
Histone deacetylase 9Homo sapiens (human)0.4616
Histone deacetylase 5Homo sapiens (human)0.4684
Nuclear receptor corepressor 2Homo sapiens (human)0.0025

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Chen, J; Kuang, P; Peng, X; Sun, Z1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1

Reviews

1 review(s) available for erlotinib and cudc-907

ArticleYear
Recent progress on HDAC inhibitors with dual targeting capabilities for cancer treatment.
    European journal of medicinal chemistry, 2020, Dec-15, Volume: 208

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Molecular Structure; Neoplasms

2020

Other Studies

1 other study(ies) available for erlotinib and cudc-907

ArticleYear
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023